Skip to content

Supernus Pharmaceuticals

US · SUPN #2636 by market cap Listed 1970
28.61 +0.26 +0.92%
Periodic snapshot; not a real-time feed. · 2026-11-20 16:48

✦ Quant Ownership Signal how this is computed

Distributing
  • The number of reporting institutions increased by 135 in the most recent period (2026/Q3).
  • Total institutional ownership fell 21.4 percentage points.

Ownership vs. money flow

Diverging

Institutions trimmed shares last reporting period, and the stock has seen net inflows in main-fund flow over the last 20 trading sessions - the two are pointing in different directions.

Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.

Institutional ownership

Held by institutions
86.15% -21.36pp
Institutions
542 +135
As of
2026/Q3 vs. prior period

Holder types

Mutual Fund55.95%
Hedge Fund23.48%
Individual/Insider3.09%
Public Company2.61%
VC/PE Fund1.78%
Government Pension Fund1.33%
Private Company0.53%
Insurance Company0.31%
Family Office/Trust0.12%
Other10.81%

Top holders as of 2026-09-30

BlackRock 8.97% · 18.63M sh
Vanguard Portfolio Management, LLC 3.36% · 6.99M sh
Millennium Management LLC 3.05% · 6.34M sh
Vanguard Capital Management, LLC 2.55% · 5.29M sh
Armistice Capital LLC 4.55% · 2.65M sh
State Street Global Advisors 2.43% · 5.04M sh
Fuller & Thaler Asset Management, Inc. 2.22% · 4.62M sh
Two Seas Capital LP 1.77% · 3.67M sh
Macquarie Investment Management Business Trust 4.09% · 2.38M sh
Morgan Stanley 1.75% · 3.64M sh
Dimensional Fund Advisors 3.58% · 2.08M sh
Assenagon Asset Management S.A. 1.70% · 3.54M sh
Jack Khattar 1.64% · 3.41M sh
Geode Capital Management, LLC 2.70% · 1.57M sh

Bar length is relative to the largest holder shown here, not to 100% of the company.

Insiders

50 filings tracked · 20 buys · 26 sells

NameRoleStake
Jack Khattar Founder, President, CEO, Secretary & Director 1.64%
Charles Newhall Independent Chairperson 0.21%
Frederick Hudson Independent Director 0.10%
Georges Gemayel Independent Director 0.02%
Carrolee Barlow Independent Director 0.02%
Frank Mottola Senior VP & Chief Technology Operations Officer 0.01%
Padmanabh Bhatt Chief Scientific Officer & Senior VP of Intellectual Property 0.01%
Jonathan Rubin Senior VP of Research & Development and Chief Medical Officer 0.01%
Timothy Dec Senior Vice President 0.01%
William Horich Chief Commercial Officer --

Insider transactions most recent Form 4 filings

DateNameRoleTypeSharesPrice
2026-08-11 Jack Khattar Founder, President, CEO, Secretary & Director Derivative Exercise and Sale -12,642 $46.57
2026-08-11 Jack Khattar Founder, President, CEO, Secretary & Director Derivative Exercise and Retained +17,207 --
2026-08-11 Timothy Dec Senior Vice President Derivative Exercise and Sale -604 $46.57
2026-08-11 Timothy Dec Senior Vice President Derivative Exercise and Retained +646 --
2026-08-11 Padmanabh Bhatt Chief Scientific Officer & Senior VP of Intellectual Property Derivative Exercise and Sale -1,158 $46.57
2026-08-11 Padmanabh Bhatt Chief Scientific Officer & Senior VP of Intellectual Property Derivative Exercise and Retained +1,342 --
2026-08-11 Jonathan Rubin Senior VP of Research & Development and Chief Medical Officer Derivative Exercise and Sale -363 $46.57
2026-08-11 Jonathan Rubin Senior VP of Research & Development and Chief Medical Officer Derivative Exercise and Retained +387 --
2026-08-11 Frank Mottola Senior VP & Chief Technology Operations Officer Derivative Exercise and Sale -797 $46.57
2026-08-11 Frank Mottola Senior VP & Chief Technology Operations Officer Derivative Exercise and Retained +853 --
2026-07-28 Jack Khattar Founder, President, CEO, Secretary & Director Other Derivative Acquisition +29,849 --
2026-07-28 Timothy Dec Senior Vice President Other Derivative Acquisition +1,250 --
2026-07-28 Padmanabh Bhatt Chief Scientific Officer & Senior VP of Intellectual Property Other Derivative Acquisition +2,500 --
2026-07-28 Jonathan Rubin Senior VP of Research & Development and Chief Medical Officer Other Derivative Acquisition +750 --
2026-07-28 Frank Mottola Senior VP & Chief Technology Operations Officer Other Derivative Acquisition +1,650 --
2026-03-17 Padmanabh Bhatt Chief Scientific Officer & Senior VP of Intellectual Property Derivative Exercise and Sale -107,250 $27.94–50.73
2026-03-16 Padmanabh Bhatt Chief Scientific Officer & Senior VP of Intellectual Property Intent to Sell (Form 144) -57,250 $50.21
2026-03-15 Padmanabh Bhatt Chief Scientific Officer & Senior VP of Intellectual Property Intent to Sell (Form 144) -50,000 $49.91
2026-03-12 Jack Khattar Founder, President, CEO, Secretary & Director Other Acquisition +12,500 --
2026-03-12 Jack Khattar Founder, President, CEO, Secretary & Director Other Disposition -12,500 --

Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.

Quote time 2026-11-20 16:48:01 · For reference only, not investment advice and not tailored to your situation.

Supernus Pharmaceuticals discussion 0 comments

Add a comment